BELITE BIO, INC ($BLTE)
Filing Information
| Accession Number | 0001193125-26-273321 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 17, 2026 |
| Document | View SEC Filing |
Transactions
8
Total Shares
10,000
Total Value
$1,405,729.41
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | American depositary share | โ | Jun 16, 2026 | Sale | 2,054 | $137.61 | $282,641.29 | 32,946 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Jun 16, 2026 | Sale | 784 | $138.18 | $108,330.53 | 32,162 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Jun 16, 2026 | Sale | 3,140 | $139.57 | $438,260.48 | 29,022 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Jun 16, 2026 | Sale | 540 | $140.58 | $75,914.71 | 28,482 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Jun 16, 2026 | Sale | 100 | $141.83 | $14,183.00 | 28,382 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Jun 16, 2026 | Sale | 450 | $142.20 | $63,988.11 | 27,932 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Jun 16, 2026 | Sale | 1,897 | $143.55 | $272,314.35 | 26,035 | Indirect | By Bioptima Ltd. | View Details | |
Chief Medical Officer | American depositary share | โ | Jun 16, 2026 | Sale | 1,035 | $145.02 | $150,096.94 | 25,000 | Indirect | By Bioptima Ltd. | View Details |